Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Kineta Inc.
Headquarters: Seattle, WA, United States of America
Website: http://www.kinetabio.com
Year Founded: 2008
Status: Public
Industry Sector: HealthTechnology
CEO: Shawn P. Iadonato, PhD
Number Of Employees: 5
Enterprise Value: $4,391,815
PE Ratio: -0.21
Exchange/Ticker 1: NASDAQ:KA
Exchange/Ticker 2: N/A
Latest Market Cap: $3,765,500
BioCentury | Jul 28, 2023
Deals
Biotech reverse mergers growing amid improving market conditions
Are 2023’s reverse mergers another sign of an improving biotech environment?
BioCentury | Jul 18, 2023
Management Tracks
Gosebruch named CEO of Neumora
Plus: Petti becomes CEO at Leucid Bio, and updates from Acelyrin, Larimar, Pharming and more
BioCentury | Jun 6, 2022
Deals
Sale of programs to J&J leaves Yumanity as shell for Kineta reverse merger
Combined company to advance Seattle biotech’s cancer programs as Yumanity’s eight-year history in neurodegeneration comes to a close
BioCentury | May 7, 2020
Finance
May 6 Quick Takes: Grail raises year’s largest venture round; plus fresh funds for Insmed, Kura, TG, BerGenBio, Limbix and Kineta
BioCentury | Feb 14, 2020
Targets & Mechanisms
Entrepreneur watch: Iwasaki targets the lymphatic system to clear brain tumors
After starting two companies this year, Yale’s Akiko Iwasaki clears glioblastoma in mice via brain lymphatics
Items per page:
1 - 10 of 30